STOCKWATCH
·
Pharmaceuticals
Investment7 Mar 2026, 01:33 pm

Aarti Drugs Ltd. to Invest INR 10 Crore in Wholly Owned Subsidiary Pinnacle Life Science

AI Summary

Aarti Drugs Ltd. has approved an investment of INR 10,00,00,000 in Pinnacle Life Science Private Limited, its wholly owned subsidiary. The investment will be made by way of subscription to the Rights Issue to finance the cost towards expansion/capex and other general corporate purposes. Pinnacle Life Science is primarily involved in the manufacturing of pharmaceutical formulations and exports its products to over 30 countries.

Key Highlights

  • Aarti Drugs Ltd. to invest INR 10 Crore in Pinnacle Life Science
  • Investment to be made by way of subscription to the Rights Issue
  • Investment proceeds to be used for expansion/capex and general corporate purposes
  • Pinnacle Life Science involved in manufacturing of pharmaceutical formulations
  • Pinnacle exports products to over 30 countries
View BSE Filing